参考文献/References:
[1] ALMAN B A,PAJERSKI M E,DIAZ-CANO S,et al.Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder[J].Diagn Mol Pathol,1997,6(2):98-101.
[2] REITAMO J J,HYRY P,NYKYRI E,et al.The desmoid tumor.I.Incidence,sex-,age- and anatomical distribution in the Finnish population[J].Am J Clin Pathol,1982,77(6):665-673.
[3] RIX T E.A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis[J].Br J Surg,2007,94(2):250-251.
[4] NUYTTENS J J,RUST P F,THOMAS C R,et al.Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors:a comparative review of 22 articles[J].Cancer,2000,88(7):1517-1523.
[5] 李云泽,赵文嫣,乔雷,等.腹壁侵袭性纤维瘤14例诊治体会[J].中国医科大学学报,2021,50(8):759-761.
LI Y Z,ZHAO W Y,QIAO L,et al.Diagnosis and treatment of 14 aggressive abdominal fibromatosis cases[J].J China Med Univ,2021,50(8):759-761.
[6] 王宁,郑浩,朱泽斌,等.腹型侵袭性纤维瘤病7例临床分析[J].安徽医药,2021,25(5):920-922.
WANG N,ZHENG H,ZHU Z B,et al.Clinical analysis of 7 cases of abdominal aggressive fibromatosis[J].Anhui Med,2021,25(5):920-922.
[7] FIORE M,RIMAREIX F,MARIANI L,et al.Desmoid-type fibromatosis:a front-line conservative approach to select patients for surgical treatment[J].Ann Surg Oncol,2009,16(9):2587-2593.
[8] 何旭昶,安文慧,曾庆彬,等.腹内型侵袭性纤维瘤的研究进展[J].胃肠病学和肝病学杂志,2020,29(7):834-838.
HE X C,AN W H,ZENG Q B,et al.Research progress of intra-abdominal aggressive fibromatosis[J].Chin J Gastroenterol Hepatol,2020,29(7):834-838.
[9] GRIGNOL V P,POLLOCK R,HOWARD J H.Management of desmoids[J].Surg Clin North Am,2016,96(5):1015-1030.
[10] HAMADA S,URAKAWA H,KOZAWA E,et al.Characteristics of cultured desmoid cells with different CTNNB1 mutation status[J].Cancer Med,2016,5(2):352-360.
[11] 王贞贞,袁耀宗.家族性腺瘤性息肉病并发侵袭性纤维瘤的危险因素分析[J].中华消化杂志,2014,34(9):640-642.
WANG Z Z,YUAN Y Z,The analysis of risk factors of developping desmoid tumours in patients with familial adenomatous polyposis[J].Chin J Dig,2014,34(9):640-642.
[12] PENEL N,KASPER B,VAN DER GRAAF W T A.Desmoid-type fibromatosis:toward a holistic management[J].Curr Opin Oncol,2021,33(4):309-314.
[13] DUMONT A G,RINK L,GODWIN A K,et al.A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis):case series of 28 patients[J].Ann Oncol,2012,23(5):1335-1340.
[14] HUANG K,FU H,SHI Y Q,et al.Prognostic factors for extra-abdominal and abdominal wall desmoids:a 20-year experience at a single institution[J].J Surg Oncol,2009,100(7):563-569.
[15] 杨明,李仕晟,杨新明.手术联合放疗治疗头颈部侵袭性纤维瘤病12例报道及文献复习[J].中国耳鼻咽喉颅底外科杂志,2012,18(5):361-363.
YANG M,LI S S,YANG X M.Management of aggressive fibromatoisis in head and neck by surgery combined with radiotherapy (A report of 12 cases and literature review)[J].Chin J Otorhinolaryngol-Skull Base Surg,2012,18(5):361-363.
[16] 宁晓燕,陈晓武,王伟福,等.内镜下粘膜剥离术治疗上消化道粘膜下肿瘤临床疗效及并发症处理[J].中国现代医药杂志,2016,18(8):19-22.
NING X Y,CHEN X W,WANG W F,et al.Efficacy and complications of endoscopic submucosal dissection on patients with upper gastrointestinal submucosal tumors[J].Mod Med J China,2016,18(8):19-22.
[17] 冷旭,王敏.SMA、Desmin、CD10和Vimentin在特殊类型子宫肿瘤诊断中的应用[J].肿瘤学杂志,2011,17(11):812-814.
LENG X,WANG M.Application of SMA,Desmin,CD10 and Vimentin in the diagnosis of the special type of uterine tumors[J].J Chin Oncol,2011,17(11):812-814.
[18] 张珊珊,祁晓莉,秦云,等.Ki-67、CD34、α-SMA、Desmin在乳腺叶状肿瘤患者中的表达及其与预后的相关性[J].医学综述,2020,26(14):2855-2858,2865.
ZHANG S S,QI X L,QIN Y,et al.Expression of Ki-67,CD34,α-SMA and Desmin in patients with phyllodes tumors of breast and its correlation with prognosis[J].Med Recapit,2020,26(14):2855-2858,2865.
[19] ZHAO W M,WANG X Y,SUN K H,et al.α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis[J].PLoS One,2018,13(1):e0191031.
[20] COHEN S.Role of calpains in promoting desmin filaments depolymerization and muscle atrophy[J].Biochim Biophys Acta Mol Cell Res,2020,1867(10):118788.